PNC Financial Services Group Inc. boosted its stake in Masimo Co. (NASDAQ:MASI – Free Report) by 21.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and ...

The global industry was valued at US$ 3.5 Bn in 2023 and is projected to cross US$ 7.4 Bn by 2034, growing at a CAGR of 7.3% ...

What a fantastic six months it’s been for Masimo. Shares of the company have skyrocketed 45.8%, hitting $167.70. This was ...

Zynex develops, manufactures, markets and sells medical devices used for nerve stimulation, pain management, and rehabilitation, as well as non-invasive fluid, sepsis, and laser-based pulse oximetry ...

M&T Bank Corp grew its position in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 4.9% in the 4th quarter, ...

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Good afternoon, ladies and gentlemen, and welcome to the Zynex ...

The draft guidance addresses criticisms that pulse oximeters are less accurate for people with dark skin tones. Experts ...

Learn more about whether Masimo Corporation or STERIS plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

9 In 2005, Masimo introduced rainbow ® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively ...